Jul 30, 2025
3 min read
In Naples, a 38-year-old suffering from Usher's syndrome will find the view thanks to a new gene therapy developed by Tigem.This is the first case in the world.
The man with Usher's disease returns to see after the test intervention in Vansvitelli Opthalmology Clinic.
The wind is an inordinated genuine, a patient of the patient with the world's first case, in the world's first case), in the world's first case), in the world's in the world
The purpose of genetic therapy is to correct genetic mutations for numerous rare diseases and the transformation of right versions of defective genes within cells.They use modified viral media that are able to transport therapeutic genetic material where it presents without causing infection.Therapy is successfully used in some diseases of the blood and immunodeficiency.
RUREERM SYDROME HOLD BY NAMECIAL COUNTS.of illness of illness, which makes all of them prove worthwhile important changes to patients.
Disability agreed for such 1b ur's based on "party party party party. The excretion of undergoing a part of the rest. It is herself to produce protein protein. Treatment tolerates to show the main positive effects of the previous days after the intervention.
The main character of this result is 38-YUARD-YOLD-YOLD-YOLD-THISEAR.Before intervention he could only meet a unknown shadow.Then it recognizes the face according to the law of law."2024, no longer looked in part and restored a large area of viewing area.
The case is part of the Luce-1 International Studio, launched at the Neapolitan Center in collaboration with London Institute. So far, besides the first patient, seven others were treated between October 2024 and April 2025. The first administration uses low doses and high therapy, demonstrating a good safety profile: no serious adverse events and eye inflammation resolved by corticosteroid therapy.The third dose of seven other patients will be tested soon.
Tigem, Televon at the Center and Medicine in Pozzuoli, is one of the most searchers in Europe in Europe in the rare trade.It is also born of aavantgarde bio.tigggarde bio.tigggarde.
The result is received by the nails celebrated by the corporation.It is defined as iuarites to change the amount of health.The Heart Commerge.Susosella initiative the public finance, to conduct the front line to offer political answers to patients.
Experiment does not stop.The next patient will receive a different dose for further tests and treatment duration.Their scientific carrier is a second carrier expanded with other descendant's eye disease associated with excessive genes for traditional operators.if confirmation.To those who think he is lost forever.Noapol again confirmed as an innovative laboratory for health services.
